Search Results - "Eser, D"

Refine Results
  1. 1

    Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? by Schüle, C, Eser, D, Baghai, T.C, Nothdurfter, C, Kessler, J.S, Rupprecht, R

    Published in Neuroscience (15-09-2011)
    “…Abstract In the past decades considerable evidence has emerged that so-called neuroactive steroids do not only act as transcriptional factors in the regulation…”
    Get full text
    Journal Article
  2. 2

    SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression by ZILL, P, BAGHAI, T. C, ZWANZGER, P, SCHÜLE, C, ESER, D, RUPPRECHT, R, MÖLLER, H.-J, BONDY, B, ACKENHEIL, M

    Published in Molecular psychiatry (01-11-2004)
    “…Tryptophan hydroxylase (TPH), being the rate-limiting enzyme in the biosynthesis of serotonin plays a major role as candidate gene in several psychiatric…”
    Get full text
    Journal Article
  3. 3

    Neuroactive steroids and affective disorders by Eser, D., Schüle, C., Baghai, T.C., Romeo, E., Uzunov, D.P., Rupprecht, R.

    Published in Pharmacology, biochemistry and behavior (01-08-2006)
    “…Neuroactive steroids modulate neurotransmission through modulation of specific neurotransmitter receptors such as γ-aminobutyric acid type A (GABA A)…”
    Get full text
    Journal Article
  4. 4

    Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism by BAGHAI, T. C, BINDER, E. B, DEIML, T, UHR, M, ILLIG, T, WICHMANN, H.-E, MODELL, S, NOTHDURFTER, C, HOLSBOER, F, MÜLLER-MYHSOK, B, MÖLLER, H.-J, RUPPRECHT, R, SCHULE, C, BONDY, B, SALYAKINA, D, ESER, D, LUCAE, S, ZWANZGER, P, HABERGER, C, ZILL, P, ISING, M

    Published in Molecular psychiatry (01-11-2006)
    “…Angiotensin-converting enzyme (ACE) is assumed to influence the activity of the hypothalamic-pituitary-adrenocortical (HPA) system, which shows hyperactivity…”
    Get full text
    Journal Article
  5. 5

    Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients by Schüle, Cornelius, Zill, Peter, Baghai, Thomas C., Eser, Daniela, Zwanzger, Peter, Wenig, Nadine, Rupprecht, Rainer, Bondy, Brigitta

    Published in Psychoneuroendocrinology (01-09-2006)
    “…Data suggest that both neurotrophic and hypothalamic–pituitary–adrenocortical (HPA) systems are involved in the pathophysiology of depression. The aim of the…”
    Get full text
    Journal Article
  6. 6

    Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity by SCHÜLE, C, ROMEO, E, UZUNOV, D. P, ESER, D, DI MICHELE, F, BAGHAI, T. C, PASINI, A, SCHWARZ, M, KEMPTER, H, RUPPRECHT, R

    Published in Molecular psychiatry (01-03-2006)
    “…Concentrations of 3α-reduced neuroactive steroids are altered in depression and normalize after antidepressant pharmacotherapy with selective serotonin…”
    Get full text
    Journal Article
  7. 7

    Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder by Zwanzger, P, Eser, D, Nothdurfter, C, Baghai, T C, Möller, H-J, Padberg, F, Rupprecht, R

    Published in Pharmacopsychiatry (01-11-2009)
    “…There is evidence that a decreased GABAergic tone plays a role in the pathophysiology of panic disorder (PD). Selective GABAergic treatment has been suggested…”
    Get more information
    Journal Article
  8. 8

    Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic-Pituitary-Adrenal-Axis Activity: A Placebo-Controlled Study by ZWANZGER, P, ESER, D, AICHER, S, SCHÜLE, C, BAGHAI, T. C, PADBERG, F, ELLA, R, MÖLLER, H-J, RUPPRECHT, R

    Published in Neuropsychopharmacology (01-05-2003)
    “…Cholecystokinin-tetrapeptide (CCK-4) induces panic attacks both in patients with panic disorder (PD) and healthy volunteers. It has been shown that panic…”
    Get full text
    Journal Article
  9. 9

    Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4 by Dieler, A C, Sämann, P G, Leicht, G, Eser, D, Kirsch, V, Baghai, T C, Karch, S, Schüle, C, Pogarell, O, Czisch, M, Rupprecht, R, Mulert, C

    Published in Current pharmaceutical design (01-11-2008)
    “…Pharmacological magnetic resonance imaging (phMRI) is a method to study effects of psychopharmacological agents on neural activation. Changes of the blood…”
    Get more information
    Journal Article
  10. 10

    Neuroactive steroids as modulators of depression and anxiety by Eser, D., Romeo, E., Baghai, T.C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., Rupprecht, R.

    Published in Neuroscience (01-01-2006)
    “…Certain neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially 3α-reduced pregnane steroids are potent positive…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients by Haefner, S, Baghai, T C, Schule, C, Eser, D, Spraul, M, Zill, P, Rupprecht, R, Bondy, B

    Published in Neuropsychobiology (01-01-2008)
    “…There is overwhelming evidence that activation of the hypothalamic-pituitary-adrenal (HPA) system plays a major role in depression and cardiovascular disease…”
    Get more information
    Journal Article
  12. 12

    The effects of alprazolam on brain activity in CCK-4-induced panic attacks by Mulert, C., Leicht, G., Eser, D., Länger, A., Karch, S., Schüle, C., Baghai, T., Pogarell, O., Meindl, T., Rupprecht, R.

    Published in NeuroImage (Orlando, Fla.) (01-07-2009)
    “…Cholecystokinine-4 (CCK-4) can be used to induce panic attacks experimentally and corrresponding fMRI activations are found in a couple of regions including…”
    Get full text
    Journal Article
  13. 13

    P02-09 - Major depression, cardiovascular risk factors and the Omega-3 index by Baghai, T.C, Varallo-Bedarida, G, Born, C, Haefner, S, Schüle, C, Eser, D, Rupprecht, R, Bondy, B, von Schacky, C

    Published in European psychiatry (2011)
    “…Introduction Cardiovascular disease (CVD) and major depressive disorders (MDD) are frequent diseases worldwide with a high comorbidity rate. Omega-3 fatty…”
    Get full text
    Journal Article
  14. 14

    Neuroactive steroids in depression and anxiety disorders: clinical studies by Eser, Daniela, Schüle, Cornelius, Baghai, Thomas C, Romeo, Elena, Rupprecht, Rainer

    Published in Neuroendocrinology (01-01-2006)
    “…Certain neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially 3alpha-reduced pregnane steroids are potent positive…”
    Get more information
    Journal Article
  15. 15

    Effects of experimentally induced panic attacks on neuroimmunological markers by de la Fontaine, L., Schwarz, M. J., Eser, D., Müller, N., Rupprecht, R., Zwanzger, P.

    Published in Journal of Neural Transmission (01-06-2009)
    “…Since little is known concerning regulation of immunological parameters in rapid changing psychiatric states like panic attacks, we measured cytokines at…”
    Get full text
    Journal Article
  16. 16

    PW01-44 - Impact of glyoxalase-1 mRNA expression on CCK-4 induced anxiety by Eser, D, Leicht, G, Laenger, A, Schuele, C, Baghai, T, Mulert, C, Uhr, M, Rupprecht, R

    Published in European psychiatry (2010)
    “…Objectives There is evidence that the antioxidant enzyme glyoxalase-1 (Glx-1) may play a role in anxiety-related behaviour. However, discordant findings…”
    Get full text
    Journal Article
  17. 17

    PW01-262 - Influence of age on effectiveness and tolerability of electroconvulsive therapy by Damm, J, Eser, D, Schuele, C, Obermeier, M, Möller, H.-J, Rupprecht, R, Baghai, T

    Published in European psychiatry (2010)
    “…Introduction The effectiveness of electroconvulsive therapy (ECT) in pharmacotherapy resistant major depression and schizophrenia has been shown for all age…”
    Get full text
    Journal Article
  18. 18

    Anticonvulsants in the treatment of anxiety--an alternative treatment option? by Zwanzger, P, Eser, D, Rupprecht, R

    Published in Nervenarzt (01-11-2007)
    “…According to epidemiological studies anxiety disorders are among the most frequent psychiatric disorders. Depending on the diagnosis and severity, both…”
    Get full text
    Journal Article
  19. 19

    Core symptoms of depression. Effectiveness of antidepressant therapy by Damm, J, Eser, D, Schüle, C, Möller, H-J, Rupprecht, R, Baghai, T C

    Published in Nervenarzt (01-05-2009)
    “…Core symptoms of depression are a combination of psychological and somatic symptoms, often associated with psychomotor and cognitive disturbances. The…”
    Get full text
    Journal Article
  20. 20